A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with azacitidine plus venetoclax for newly diagnosed acute myeloid leukemia.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/can-alternating-venetoclax-regimens-improve-aml-outcomes-2026a1000e0d?src=rss
Author :
Publish date : 2026-05-01 14:16:00
Copyright for syndicated content belongs to the linked Source.